ADMA Biologics Inc (ADMA) — Cash Flow Quality Index
ADMA Biologics Inc (ADMA) has a Cash Flow Quality Index of 0.78x as of June 2026. Operating cash flow of $29.54 Million is below net income of $37.82 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ADMA Biologics Inc (ADMA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ADMA Biologics Inc Cash Flow Quality Index (2024–2025)
Historical Cash Flow Quality Index for ADMA Biologics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of ADMA Biologics Inc.
Annual Cash Flow Quality Index for ADMA Biologics Inc (2024–2025)
Year-by-year earnings quality comparison for ADMA Biologics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | $50.40 Million | $146.93 Million | ▼ -42.9% |
| 2024 | 0.60x | $118.67 Million | $197.67 Million | — |